Pulse Electromagnetic Field Therapy Devices Market

Surge in geriatric population silently triggers the demand for pulse electromagnetic field therapy devices market: Opportunities ahead

Pulse Electromagnetic Field Therapy Devices Market by Component, Application, End-use & Region | Forecast 2022 to 2032

Pulse Electromagnetic Field Therapy Devices Market Outlook (2022 to 2032)

Newly-released Pulse Electromagnetic Field Therapy Devices Market industry analysis report by Future Market Insights shows that global sales of the Pulse Electromagnetic Field Therapy Devices Market in 2021 were held at US$ 416.6 million. With 8.6%, the projected market growth from 2022 to 2032 is expected to be higher than the historical growth. The market through the Low-Frequency segment is expected to gross the highest revenue, accounting for a CAGR of nearly 8.8% from 2022 to 2032.

Attribute	Details
Global Pulse Electromagnetic Field Therapy Devices Market (2022)	US$ 452.4 million
Global Pulse Electromagnetic Field Therapy Devices Market (2032)	US$ 1 billion
Global Pulse Electromagnetic Field Therapy Devices Market CAGR (2022 to 2032)	8.6%
USA Pulse Electromagnetic Field Therapy Devices Market CAGR (2022 to 2032)	8%
Key Companies Profiled	Bedfont Scientific Orthofix Holdings Nuage Health Bemer Oxford Medical Instruments Health OSKA Medithera NiuDeSai I-Tech Medical Division

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Revenue of Pulse Electromagnetic Field Therapy Devices Market from 2017 to 2021 Compared to Demand Outlook for 2022 to 2032

As per the Pulse Electromagnetic Field Therapy Devices Market industry research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Pulse Electromagnetic Field Therapy Devices Market industry increased at around 7.8% CAGR. Countries such as the USA, United Kingdom, China, Japan, and, South Korea held a significant share of the global market.

PEMF (pulsed electromagnetic field) therapy devices are non-invasive and have no known negative effects. PEMF therapy is a treatment option for a variety of musculoskeletal problems. The FDA has approved PEMF devices for the treatment of non-union fractures as well as post-operative osteoarthritis, plantar fasciitis, discomfort, and edema.

These devices also have a number of advantages, including the reduction of chronic and acute pain associated with a variety of connective tissues, such as bone, tendon, ligament, and cartilage injury, as well as the control of edema and inflammation. As a result, the advantages of these devices are expected to drive market expansion.

The market is expected to rise due to an increase in the global elderly population and increased awareness of pulse electromagnetic field (PEMF) therapy devices. The market position is projected to be secured by technological improvements including the development of narrow, downsized PEMF therapeutic devices employing sophisticated materials. The addition of telemedicine is likely to broaden the range of applications for these devices.

Severe spinal injuries, as well as delayed union and non-union fractures, are the most common outcomes of road accidents and trauma, necessitating surgical intervention. During the treatment of failed spinal fusions, delayed unions, fracture non-union, and new fractures, PEMF therapy devices stimulate bone repair.

The International Osteoporosis Foundation estimates that osteoporosis causes 8.9 million fractures per year. Furthermore, approximately 1.6 million hip fractures occur globally each year, with this figure expected to rise to between 4.5 and 6.3 million by 2050. As a result, the demand for PEMF therapy devices is likely to rise as the number of instances of osteoporosis rises.

Which factors are responsible for the growth of the Pulse Electromagnetic Field Therapy Devices Market?

The surge in the number of fractures due to falls, accidents, and sports injuries and Poor conditions of roads in various countries are some of the factors responsible for the growth of the market. Fractures caused by sports injuries, accidents, falls from a certain height, and symptoms such as arthritis, knee discomfort, and joint pain affect a major section of people around the world.

According to WHO figures, around 1.3 million people die each year as a result of traffic accidents. Furthermore, low- and middle-income countries account for the majority of worldwide traffic fatalities. Poorly maintained roads can result in a variety of injuries and pain in various body areas.

Potholes, uneven roads, broken surfaces, and road cracking can all cause injury to pedestrians, necessitating medical attention. Furthermore, governments' lack of focus on improving road infrastructure raises the risk of accidents and other injuries that can cause significant pain, raising healthcare expenses for individuals.

Interventional Orthopaedics of Atlanta is promoting PEMF therapy, an orthopedic clinic in Atlanta, Georgia, for the treatment of chronic tiredness symptoms, osteoporosis, and poor wound healing. The market for pulse electromagnetic field therapy devices in the United States is growing as a result of these discoveries.

PEMF technology is known for generating energy in the body's cells without requiring invasive surgery. For enterprises in the pulse electromagnetic field (PEMF) therapeutic equipment industry, such advantages translate into value-grab opportunities. PEMF therapy boosts the body's natural function by amplifying the body's natural energy. This therapy aids in the improvement of sports performance as well as the speedier recovery of injuries.

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Mild Adverse Reactions in Patients Influencing Market Growth. Check How?

Because electromagnetic therapies cause a wide range of interactions within the body, some patients have reported discomfort during their first sessions. As a result, these occurrences occur seldom during the initial stages of treatment. Mild side effects are more common with whole-body treatments and, in rare situations, local therapies.

PEMF side effects are small and transitory, and they normally go away after the therapy is continued. Furthermore, people with electromagnetic hypersensitivity are more likely to have these side effects. Patients may experience overreactions because PEMF therapy has the power to modify biological systems and excite cells or tissues.

Country-wise Analysis

The USA Pulse Electromagnetic Field Therapy Devices Market Analysis

United States remains the most dominant country in the Pulse Electromagnetic Field Therapy Market having the expected largest market share of US$ 358.3 million by 2032. The demand for PEMF therapy devices in the United States is expected to rise as the number of individuals suffering from osteoporosis and osteoarthritis rises. Furthermore, the growing shift to minimally invasive procedures is expected to boost regional growth. In addition, the presence of a well-developed healthcare system in the United States is expected to stimulate the demand.

The United Kingdom Pulse Electromagnetic Field Therapy Devices Market Analysis

The market in the United Kingdom is projected to reach a valuation of US$ 48 million by 2032. With a CAGR of 9.8% from 2022 to 2032, the market is expected to gross an absolute dollar opportunity of US$ 29 million during the forecast period.

Japan Pulse Electromagnetic Field Therapy Devices Market Analysis

In Japan, the market is expected to reach US$ 46 million by 2032. The market in the country is projected to gross an absolute dollar opportunity of US$ 31 million during the forecast period, growing at a CAGR of 11.6%.

South Korea Pulse Electromagnetic Field Therapy Devices Market Analysis

The market in South Korea is projected to witness an absolute dollar opportunity of US$ 9.6 million during the forecast period. By 2032, the market in the country is likely to reach US$ 17 million by 2032, growing at a CAGR of 8.5%.

Category-wise Insights

Which Component Type is expected to grow the fastest among the other segments?

The Low-Frequency pulsed electromagnetic field therapy devices market is expected to account for the highest CAGR of 8.8%. Low-frequency PEMF devices generate magnetic fields with frequencies that are medium-high but low in intensity. These devices may also be used to address hard tissues and delayed bone growth. Low-frequency PEMF devices are used to treat rheumatoid arthritis inflammation, pain, and impairments in a quick, non-invasive, and simple way. As a result, the use of low-frequency PEMF therapy devices for arthritis treatment is likely to drive growth.

Competitive Analysis

Some of the players operating in the pulse electromagnetic field therapy devices market include Bedfont Scientific, Orthofix Holdings, Nuage Health, Bemer, Oxford Medical Instruments Health, OSKA, Medithera, NiuDeSai, and I-Tech Medical Division.

Some of the recent developments of key players in the Pulse Electromagnetic Field Therapy Devices Market are as follows:

In August 2021, BEMER, released its latest Go-Edition to help people improve their health and well-being while on the go. A low-intensity pulsed electromagnetic field (PEMF) is used in the new portable set to increase muscle conditioning, performance, strength, and recuperation. Furthermore, the Go-Edition is an FDA-approved Class 11 medical device.
In April 2021, Orthofix entered into an agreement with IGEA S.p.A., a biomedical company that specializes in biophysical therapeutics. The current agreement enabled the companies to collaborate on expanding the range of their bone, cartilage, and soft tissue stimulation treatments all over the United States.
In September 2020, OSKA Wellness' OSKA Pulse technology-enabled products were introduced in India. PETF technology used by OSKA Pulse has been scientifically tested to be effective in increasing the functionality of patients who have motor difficulties, had back problems, or had been in calf pain, among other conditions.
In February 2020, Orthofix launched the new STIM onTrack mobile app version 2.1, which allows for enhancing the treatment with CervicalStim, SpinalStim, and PhysioStim bone growth stimulators by assisting patients to share PROM data remotely along with device usage data.

Similarly, recent developments related to companies offering Pulse Electromagnetic Field Therapy Devices Market have been tracked by the team at Future Market Insights, which is available in the full report.

Market Segments Covered in Pulse Electromagnetic Field Therapy Devices Industry Analysis

By Component:

Low Frequency
High Frequency

By Application:

Bone Growth
Pain Management
Other Applications

By End-use:

Home Care Settings
Hospitals
Other End-uses

By Region:

North America
Europe
Asia Pacific
Latin America
Middle East and Africa (MEA)

Frequently Asked Questions

How much is the current worth of the Pulse Electromagnetic Field Therapy Devices Market?

The global Pulse Electromagnetic Field Therapy Devices Market is worth more than US$ 416.6 Million at present.

What is the sales forecast for Pulse Electromagnetic Field Therapy Devices Market?

The value of the Pulse Electromagnetic Field Therapy Devices Market is projected to increase at a CAGR of around 8.6% during 2022 to 2032.

What was the last 5 year’s market CAGR?

The value of the Pulse Electromagnetic Field Therapy Devices Market increased at a CAGR of around 7.8% from 2017 to 2021.

Which segment accounted for the fastest-growing segment in Pulse Electromagnetic Field Therapy Devices Market?

With a CAGR of 8.3% historically, Low-Frequency segment dominated the Pulse Electromagnetic Field Therapy Devices industry.

Which are the top countries driving demand for Pulse Electromagnetic Field Therapy Devices Market?

The top 5 countries driving demand for Pulse Electromagnetic Field Therapy Devices Market are the USA, the United Kingdom., China, Japan, and South Korea.

At what percentage is revenue of Pulse Electromagnetic Field Therapy Devices Market going to register growth in Japan?

The Japanese market for Pulse Electromagnetic Field Therapy Devices is projected to expand at a CAGR of around 11.6% during 2022 to 2032.

What do statistics for South Korea and the United Kingdom reveal?

While the market in South Korea is expected to grow at nearly 8.5%, the market in the United Kingdom is projected to register a CAGR of nearly 9.8% from 2022 to 2032.

Table of Content

1. Executive Summary| Pulse Electromagnetic Field Therapy Devices Market

1.1. Global Market Outlook

1.2. Summary of Statistics

1.3. Key Market Characteristics & Attributes

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

3.1. Risk Assessment

3.1.1. COVID-19 Crisis and Impact on Market

3.1.2. COVID-19 Impact Benchmark with Previous Crisis

3.1.3. Impact on Market Value (US$ million)

3.1.4. Assessment by Key Countries

3.1.5. Assessment by Key Market Segments

3.1.6. Action Points and Recommendation for Suppliers

3.2. Key Trends Impacting the Market

3.3. Formulation and Product Development Trends

4. Market Background

4.1. Market, by Key Countries

4.2. Market Opportunity Assessment (US$ million)

4.2.1. Total Available Market

4.2.2. Serviceable Addressable Market

4.2.3. Serviceable Obtainable Market

4.3. Market Scenario Forecast

4.3.1. Demand in optimistic Scenario

4.3.2. Demand in Likely Scenario

4.3.3. Demand in Conservative Scenario

4.4. Investment Feasibility Analysis

4.4.1. Investment in Established Markets

4.4.1.1. In Short Term

4.4.1.2. In Long Term

4.4.2. Investment in Emerging Markets

4.4.2.1. In Short Term

4.4.2.2. In Long Term

4.5. Forecast Factors - Relevance & Impact

4.5.1. Top Companies Historical Growth

4.5.2. Growth in Automation, By Country

4.5.3. Patch Management Adoption Rate, By Country

4.6. Market Dynamics

4.6.1. Market Driving Factors and Impact Assessment

4.6.2. Prominent Market Challenges and Impact Assessment

4.6.3. Patch Management Market Opportunities

4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

5.2. Banking on with Segments High Incremental Opportunity

5.3. Peer Benchmarking

6. Global Market Demand Analysis 2017 to 2021 and Forecast, 2022 to 2032

6.1. Historical Market Analysis, 2017 to 2021

6.2. Current and Future Market Projections, 2022 to 2032

6.3. Y-o-Y Growth Trend Analysis

7. Global Market Value Analysis 2017 to 2021 and Forecast, 2022 to 2032

7.1. Historical Market Value (US$ million) Analysis, 2017 to 2021

7.2. Current and Future Market Value (US$ million) Projections, 2022 to 2032

7.2.1. Y-o-Y Growth Trend Analysis

7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Component

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ million) Analysis By Component, 2017 to 2021

8.3. Current and Future Market Size (US$ million) Analysis and Forecast By Component, 2022 to 2032

8.3.1. Low Frequency

8.3.2. High Frequency

8.4. Market Attractiveness Analysis By Component

9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Application

9.1. Introduction / Key Findings

9.2. Historical Market Size (US$ million) Analysis By Application, 2017 to 2021

9.3. Current and Future Market Size (US$ million) Analysis and Forecast By Application, 2022 to 2032

9.3.1. Bone Growth

9.3.2. Pain Management

9.3.3. Other Applications

9.4. Market Attractiveness Analysis By Application

10. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End-use

10.1. Introduction / Key Findings

10.2. Historical Market Size (US$ million) Analysis By End-use, 2017 to 2021

10.3. Current and Future Market Size (US$ million) Analysis and Forecast By End-use, 2022 to 2032

10.3.1. Home Care Settings

10.3.2. Hospitals

10.3.3. Other End-uses

10.4. Market Attractiveness Analysis By End-use

11. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region

11.1. Introduction

11.2. Historical Market Size (US$ million) Analysis By Region, 2017 to 2021

11.3. Current Market Size (US$ million) & Analysis and Forecast By Region, 2022 to 2032

11.3.1. North America

11.3.2. Latin America

11.3.3. Europe

11.3.4. APAC

11.3.5. Middle East and Africa (MEA)

11.4. Market Attractiveness Analysis By Region

12. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032

12.1. Introduction

12.2. Pricing Analysis

12.3. Historical Market Size (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021

12.4. Market Size (US$ million) & Forecast By Market Taxonomy, 2022 to 2032

12.4.1. By Country

12.4.1.1. The USA

12.4.1.2. Canada

12.4.1.3. Rest of North America

12.4.2. By Component

12.4.3. By End-use

12.4.4. By Application

12.5. Market Attractiveness Analysis

12.5.1. By Country

12.5.2. By Component

12.5.3. By End-use

12.5.4. By Application

13. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032

13.1. Introduction

13.2. Pricing Analysis

13.3. Historical Market Size (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021

13.4. Market Size (US$ million) & Forecast By Market Taxonomy, 2022 to 2032

13.4.1. By Country

13.4.1.1. Brazil

13.4.1.2. Mexico

13.4.1.3. Rest of Latin America

13.4.2. By Component

13.4.3. By End-use

13.4.4. By Application

13.5. Market Attractiveness Analysis

13.5.1. By Country

13.5.2. By Component

13.5.3. By End-use

13.5.4. By Application

14. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032

14.1. Introduction

14.2. Pricing Analysis

14.3. Historical Market Size (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021

14.4. Market Size (US$ million) & Forecast By Market Taxonomy, 2022 to 2032

14.4.1. By Country

14.4.1.1. Germany

14.4.1.2. France

14.4.1.3. The United Kingdom

14.4.1.4. Italy

14.4.1.5. Netherlands

14.4.1.6. Belgium

14.4.1.7. Rest of Europe

14.4.2. By Component

14.4.3. By End-use

14.4.4. By Application

14.5. Market Attractiveness Analysis

14.5.1. By Country

14.5.2. By Component

14.5.3. By End-use

14.5.4. By Application

15. APAC Market Analysis 2017 to 2021 and Forecast 2022 to 2032

15.1. Introduction

15.2. Pricing Analysis

15.3. Historical Market Size (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021

15.4. Market Size (US$ million) & Forecast By Market Taxonomy, 2022 to 2032

15.4.1. By Country

15.4.1.1. China

15.4.1.2. Japan

15.4.1.3. South Korea

15.4.1.4. Rest of APAC

15.4.2. By Component

15.4.3. By End-use

15.4.4. By Application

15.5. Market Attractiveness Analysis

15.5.1. By Country

15.5.2. By Component

15.5.3. By End-use

15.5.4. By Application

16. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032

16.1. Introduction

16.2. Pricing Analysis

16.3. Historical Market Size (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021

16.4. Market Size (US$ million) & Forecast By Market Taxonomy, 2022 to 2032

16.4.1. By Country

16.4.1.1. Saudi Arabia

16.4.1.2. South Africa

16.4.1.3. Nigeria

16.4.1.4. Rest of Middle East and Africa

16.4.2. By Component

16.4.3. By End-use

16.4.4. By Application

16.5. Market Attractiveness Analysis

16.5.1. By Country

16.5.2. By Component

16.5.3. By End-use

16.5.4. By Application

17. Key Countries Market Analysis 2017 to 2021 and Forecast 2022 to 2032

17.1. Introduction

17.1.1. Market Value Proportion Analysis, By Key Countries

17.1.2. Global Vs. Country Growth Comparison

17.2. US Market Analysis

17.2.1. Value Proportion Analysis by Market Taxonomy

17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032

17.2.2.1. By Component

17.2.2.2. By End-use

17.2.2.3. By Application

17.3. Canada Market Analysis

17.3.1. Value Proportion Analysis by Market Taxonomy

17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032

17.3.2.1. By Component

17.3.2.2. By End-use

17.3.2.3. By Application

17.4. Mexico Market Analysis

17.4.1. Value Proportion Analysis by Market Taxonomy

17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032

17.4.2.1. By Component

17.4.2.2. By End-use

17.4.2.3. By Application

17.5. Brazil Market Analysis

17.5.1. Value Proportion Analysis by Market Taxonomy

17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032

17.5.2.1. By Component

17.5.2.2. By End-use

17.5.2.3. By Application

17.6. Germany Market Analysis

17.6.1. Value Proportion Analysis by Market Taxonomy

17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032

17.6.2.1. By Component

17.6.2.2. By End-use

17.6.2.3. By Application

17.7. France Market Analysis

17.7.1. Value Proportion Analysis by Market Taxonomy

17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032

17.7.2.1. By Component

17.7.2.2. By End-use

17.7.2.3. By Application

17.8. Italy Market Analysis

17.8.1. Value Proportion Analysis by Market Taxonomy

17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032

17.8.2.1. By Component

17.8.2.2. By End-use

17.8.2.3. By Application

17.9. Netherlands Market Analysis

17.9.1. Value Proportion Analysis by Market Taxonomy

17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032

17.9.2.1. By Component

17.9.2.2. By End-use

17.9.2.3. By Application

17.10. United Kingdom Market Analysis

17.10.1. Value Proportion Analysis by Market Taxonomy

17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032

17.10.2.1. By Component

17.10.2.2. By End-use

17.10.2.3. By Application

17.11. Belgium Market Analysis

17.11.1. Value Proportion Analysis by Market Taxonomy

17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032

17.11.2.1. By Component

17.11.2.2. By End-use

17.11.2.3. By Application

17.12. China Market Analysis

17.12.1. Value Proportion Analysis by Market Taxonomy

17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032

17.12.2.1. By Component

17.12.2.2. By End-use

17.12.2.3. By Application

17.13. Japan Market Analysis

17.13.1. Value Proportion Analysis by Market Taxonomy

17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032

17.13.2.1. By Component

17.13.2.2. By End-use

17.13.2.3. By Application

17.14. South Korea Market Analysis

17.14.1. Value Proportion Analysis by Market Taxonomy

17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032

17.14.2.1. By Component

17.14.2.2. By End-use

17.14.2.3. By Application

17.15. Saudi Arabia Market Analysis

17.15.1. Value Proportion Analysis by Market Taxonomy

17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032

17.15.2.1. By Component

17.15.2.2. By End-use

17.15.2.3. By Application

17.16. South Africa Market Analysis

17.16.1. Value Proportion Analysis by Market Taxonomy

17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032

17.16.2.1. By Component

17.16.2.2. By End-use

17.16.2.3. By Application

17.17. Nigeria Market Analysis

17.17.1. Value Proportion Analysis by Market Taxonomy

17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032

17.17.2.1. By Component

17.17.2.2. By End-use

17.17.2.3. By Application

17.17.3. Competition Landscape and Player Concentration in the Country

18. Market Structure Analysis

18.1. Market Analysis by Tier of Companies

18.2. Market Concentration

18.3. Market Share Analysis of Top Players

18.4. Market Presence Analysis

18.4.1. By Regional footprint of Players

18.4.2. Product footprint by Players

19. Competition Analysis

19.1. Competition Dashboard

19.2. Competition Benchmarking

19.3. Competition Deep Dive

19.3.1. Bedfont Scientific

19.3.1.1. Overview

19.3.1.2. Product Portfolio

19.3.1.3. Sales Footprint

19.3.1.4. Strategy Overview

19.3.2. Orthofix Holdings

19.3.2.1. Overview

19.3.2.2. Product Portfolio

19.3.2.3. Sales Footprint

19.3.2.4. Strategy Overview

19.3.3. Nuage Health

19.3.3.1. Overview

19.3.3.2. Product Portfolio

19.3.3.3. Sales Footprint

19.3.3.4. Strategy Overview

19.3.4. Bemer

19.3.4.1. Overview

19.3.4.2. Product Portfolio

19.3.4.3. Sales Footprint

19.3.4.4. Strategy Overview

19.3.5. Oxford Medical Instruments Health

19.3.5.1. Overview

19.3.5.2. Product Portfolio

19.3.5.3. Sales Footprint

19.3.5.4. Strategy Overview

19.3.6. OSKA

19.3.6.1. Overview

19.3.6.2. Product Portfolio

19.3.6.3. Sales Footprint

19.3.6.4. Strategy Overview

19.3.7. Medithera

19.3.7.1. Overview

19.3.7.2. Product Portfolio

19.3.7.3. Sales Footprint

19.3.7.4. Strategy Overview

19.3.8. NiuDeSai

19.3.8.1. Overview

19.3.8.2. Product Portfolio

19.3.8.3. Sales Footprint

19.3.8.4. Strategy Overview

19.3.9. I-Tech Medical Division

19.3.9.1. Overview

19.3.9.2. Product Portfolio

19.3.9.3. Sales Footprint

19.3.9.4. Strategy Overview

20. Assumptions and Acronyms Used

21. Research Methodology

List of Tables

Table 1: Global Market Value (US$ million), By Component, 2017 to 2021

Table 2: Global Market Value (US$ million), By Component, 2022 to 2032

Table 3: Global Market Value (US$ million), By End-use, 2017 to 2021

Table 4: Global Market Value (US$ million), By End-use, 2022 to 2032

Table 5: Global Market Value (US$ million), By Application, 2017 to 2021

Table 6: Global Market Value (US$ million), By Application, 2022 to 2032

Table 7: Global Market, By Region, 2017 to 2021

Table 8: Global Market, By Region, 2022 to 2032

Table 9: North America Market Value (US$ million), By Component, 2017 to 2021

Table 10: North America Market Value (US$ million), By Component, 2022 to 2032

Table 11: North America Market Value (US$ million), By End-use, 2017 to 2021

Table 12: North America Market Value (US$ million), By End-use, 2022 to 2032

Table 13: North America Market Value (US$ million), By Application, 2017 to 2021

Table 14: North America Market Value (US$ million), By Application, 2022 to 2032

Table 15: North America Market, By Country, 2017 to 2021

Table 16: North America Market, By Country, 2022 to 2032

Table 17: Latin America Market Value (US$ million), By Component, 2017 to 2021

Table 18: Latin America Market Value (US$ million), By Component, 2022 to 2032

Table 19: Latin America Market Value (US$ million), By End-use, 2017 to 2021

Table 20: Latin America Market Value (US$ million), By End-use, 2022 to 2032

Table 21: Latin America Market Value (US$ million), By Application, 2017 to 2021

Table 22: Latin America Market Value (US$ million), By Application, 2022 to 2032

Table 23: Latin America Market, By Country, 2017 to 2021

Table 24: Latin America Market, By Country, 2022 to 2032

Table 25: Europe Market Value (US$ million), By Component, 2017 to 2021

Table 26: Europe Market Value (US$ million), By Component, 2022 to 2032

Table 27: Europe Market Value (US$ million), By End-use, 2017 to 2021

Table 28: Europe Market Value (US$ million), By End-use, 2022 to 2032

Table 29: Europe Market Value (US$ million), By Application, 2017 to 2021

Table 30: Europe Market Value (US$ million), By Application, 2022 to 2032

Table 31: Europe Market, By Country, 2017 to 2021

Table 32: Europe Market, By Country, 2022 to 2032

Table 33: APAC Market Value (US$ million), By Component, 2017 to 2021

Table 34: APAC Market Value (US$ million), By Component, 2022 to 2032

Table 35: APAC Market Value (US$ million), By End-use, 2017 to 2021

Table 36: APAC Market Value (US$ million), By End-use, 2022 to 2032

Table 37: APAC Market Value (US$ million), By Application, 2017 to 2021

Table 38: APAC Market Value (US$ million), By Application, 2022 to 2032

Table 39: APAC Market, By Country, 2017 to 2021

Table 40: APAC Market, By Country, 2022 to 2032

Table 41: MEA Market Value (US$ million), By Component, 2017 to 2021

Table 42: MEA Market Value (US$ million), By Component, 2022 to 2032

Table 43: MEA Market Value (US$ million), By End-use, 2017 to 2021

Table 44: MEA Market Value (US$ million), By End-use, 2022 to 2032

Table 45: MEA Market Value (US$ million), By Application, 2017 to 2021

Table 46: MEA Market Value (US$ million), By Application, 2022 to 2032

Table 47: MEA Market, By Country, 2017 to 2021

Table 48: MEA Market, By Country, 2022 to 2032

Table 49: Global Market Incremental $ Opportunity, By Component, 2017 to 2021

Table 50: Global Market Incremental $ Opportunity, By End-use, 2022 to 2032

Table 51: Global Market Incremental $ Opportunity, By Application, 2017 to 2021

Table 52: Global Market Incremental $ Opportunity, By Region, 2022 to 2032

Table 53: North America Market Incremental $ Opportunity, By Component, 2017 to 2021

Table 54: North America Market Incremental $ Opportunity, By End-use, 2022 to 2032

Table 55: North America Market Incremental $ Opportunity, By Application, 2017 to 2021

Table 56: North America Market Incremental $ Opportunity, By Country, 2022 to 2032

Table 57: Latin America Market Incremental $ Opportunity, By Component, 2017 to 2021

Table 58: Latin America Market Incremental $ Opportunity, By End-use, 2022 to 2032

Table 59: Latin America Market Incremental $ Opportunity, By Application, 2017 to 2021

Table 60: Latin America Market Incremental $ Opportunity, By Country, 2022 to 2032

Table 61: Europe Market Incremental $ Opportunity, By Component, 2017 to 2021

Table 62: Europe Market Incremental $ Opportunity, By End-use, 2022 to 2032

Table 63: Europe Market Incremental $ Opportunity, By Application, 2017 to 2021

Table 64: Europe Market Incremental $ Opportunity, By Country, 2022 to 2032

Table 65: APAC Market Incremental $ Opportunity, By Component, 2017 to 2021

Table 66: APAC Market Incremental $ Opportunity, By End-use, 2022 to 2032

Table 67: APAC Market Incremental $ Opportunity, By Application, 2017 to 2021

Table 68: APAC Market Incremental $ Opportunity, By Country, 2022 to 2032

Table 69: MEA Market Incremental $ Opportunity, By Component, 2017 to 2021

Table 70: MEA Market Incremental $ Opportunity, By End-use, 2022 to 2032

Table 71: MEA Market Incremental $ Opportunity, By Application, 2017 to 2021

Table 72: MEA Market Incremental $ Opportunity, By Country, 2022 to 2032

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Market Value (US$ million) and Year-on-Year Growth, 2017 to 2032

Figure 2: Global Market Absolute $ Historical Gain (2017 to 2021) and Opportunity (2022 to 2032), US$ million

Figure 3: Global Market Share, By Component, 2022 to 2032

Figure 4: Global Market Y-o-Y Growth Projections, By Component - 2022 to 2032

Figure 5: Global Market Attractiveness Index, By Component - 2022 to 2032

Figure 6: Global Market Share, By End-use, 2022 to 2032

Figure 7: Global Market Y-o-Y Growth Projections, By End-use - 2022 to 2032

Figure 8: Global Market Attractiveness Index, By End-use - 2022 to 2032

Figure 9: Global Market Share, By Application, 2022 to 2032

Figure 10: Global Market Y-o-Y Growth Projections, By Application - 2022 to 2032

Figure 11: Global Market Attractiveness Index, By Application - 2022 to 2032

Figure 12: Global Market Share, By Region, 2022 to 2032

Figure 13: Global Market Y-o-Y Growth Projections, By Region - 2022 to 2032

Figure 14: Global Market Attractiveness Index, By Region - 2022 to 2032

Figure 15: North America Market Value (US$ million) and Year-on-Year Growth, 2017 to 2032

Figure 16: North America Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ million

Figure 17: North America Market Share, By Component, 2022 to 2032

Figure 18: North America Market Y-o-Y Growth Projections, By Component - 2022 to 2032

Figure 19: North America Market Attractiveness Index, By Component - 2022 to 2032

Figure 20: North America Market Share, By End-use, 2022 to 2032

Figure 21: North America Market Y-o-Y Growth Projections, By End-use - 2022 to 2032

Figure 22: North America Market Attractiveness Index, By End-use - 2022 to 2032

Figure 23: North America Market Share, By Application, 2022 to 2032

Figure 24: North America Market Y-o-Y Growth Projections, By Application - 2022 to 2032

Figure 25: North America Market Attractiveness Index, By Application - 2022 to 2032

Figure 26: North America Market Share, By Country, 2022 to 2032

Figure 27: North America Market Y-o-Y Growth Projections, By Country - 2022 to 2032

Figure 28: North America Market Attractiveness Index, By Country - 2022 to 2032

Figure 29: Latin America Market Value (US$ million) and Year-on-Year Growth, 2017 to 2032

Figure 30: Latin America Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ million

Figure 31: Latin America Market Share, By Component, 2022 to 2032

Figure 32: Latin America Market Y-o-Y Growth Projections, By Component - 2022 to 2032

Figure 33: Latin America Market Attractiveness Index, By Component - 2022 to 2032

Figure 34: Latin America Market Share, By End-use, 2022 to 2032

Figure 35: Latin America Market Y-o-Y Growth Projections, By End-use - 2022 to 2032

Figure 36: Latin America Market Attractiveness Index, By End-use - 2022 to 2032

Figure 37: Latin America Market Share, By Application, 2022 to 2032

Figure 38: Latin America Market Y-o-Y Growth Projections, By Application - 2022 to 2032

Figure 39: Latin America Market Attractiveness Index, By Application - 2022 to 2032

Figure 40: Latin America Market Share, By Country, 2022 to 2032

Figure 41: Latin America Market Y-o-Y Growth Projections, By Country - 2022 to 2032

Figure 42: Latin America Market Attractiveness Index, By Country - 2022 to 2032

Figure 43: Europe Market Value (US$ million) and Year-on-Year Growth, 2017 to 2032

Figure 44: Europe Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ million

Figure 45: Europe Market Share, By Component, 2022 to 2032

Figure 46: Europe Market Y-o-Y Growth Projections, By Component - 2022 to 2032

Figure 47: Europe Market Attractiveness Index, By Component - 2022 to 2032

Figure 48: Europe Market Share, By End-use, 2022 to 2032

Figure 49: Europe Market Y-o-Y Growth Projections, By End-use - 2022 to 2032

Figure 50: Europe Market Attractiveness Index, By End-use - 2022 to 2032

Figure 51: Europe Market Share, By Application, 2022 to 2032

Figure 52: Europe Market Y-o-Y Growth Projections, By Application - 2022 to 2032

Figure 53: Europe Market Attractiveness Index, By Application - 2022 to 2032

Figure 54: Europe Market Share, By Country, 2022 to 2032

Figure 55: Europe Market Y-o-Y Growth Projections, By Country - 2022 to 2032

Figure 56: Europe Market Attractiveness Index, By Country - 2022 to 2032

Figure 57: MEA Market Value (US$ million) and Year-on-Year Growth, 2017 to 2032

Figure 58: MEA Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ million

Figure 59: MEA Market Share, By Component, 2022 to 2032

Figure 60: MEA Market Y-o-Y Growth Projections, By Component - 2022 to 2032

Figure 61: MEA Market Attractiveness Index, By Component - 2022 to 2032

Figure 62: MEA Market Share, By End-use, 2022 to 2032

Figure 63: MEA Market Y-o-Y Growth Projections, By End-use - 2022 to 2032

Figure 64: MEA Market Attractiveness Index, By End-use - 2022 to 2032

Figure 65: MEA Market Share, By Application, 2022 to 2032

Figure 66: MEA Market Y-o-Y Growth Projections, By Application - 2022 to 2032

Figure 67: MEA Market Attractiveness Index, By Application - 2022 to 2032

Figure 68: MEA Market Share, By Country, 2022 to 2032

Figure 69: MEA Market Y-o-Y Growth Projections, By Country - 2022 to 2032

Figure 70: MEA Market Attractiveness Index, By Country - 2022 to 2032

Figure 71: APAC Market Value (US$ million) and Year-on-Year Growth, 2017 to 2032

Figure 72: APAC Market Absolute $ Opportunity Historical (2017 to 2021) and Forecast Period (2022 to 2032), US$ million

Figure 73: APAC Market Share, By Component, 2022 to 2032

Figure 74: APAC Market Y-o-Y Growth Projections, By Component - 2022 to 2032

Figure 75: APAC Market Attractiveness Index, By Component - 2022 to 2032

Figure 76: APAC Market Share, By End-use, 2022 to 2032

Figure 77: APAC Market Y-o-Y Growth Projections, By End-use - 2022 to 2032

Figure 78: APAC Market Attractiveness Index, By End-use - 2022 to 2032

Figure 79: APAC Market Share, By Application, 2022 to 2032

Figure 80: APAC Market Y-o-Y Growth Projections, By Application - 2022 to 2032

Figure 81: APAC Market Attractiveness Index, By Application - 2022 to 2032

Figure 82: APAC Market Share, By Country, 2022 to 2032

Figure 83: APAC Market Y-o-Y Growth Projections, By Country - 2022 to 2032

Figure 84: APAC Market Attractiveness Index, By Country - 2022 to 2032

Figure 85: US Market Value (US$ million) and Forecast, 2022 to 2032

Figure 86: US Market Share, By Component, 2021

Figure 87: US Market Share, By End-use, 2021

Figure 88: US Market Share, By Application, 2021

Figure 89: Canada Market Value (US$ million) and Forecast, 2022 to 2032

Figure 90: Canada Market Share, By Component, 2021

Figure 91: Canada Market Share, By End-use, 2021

Figure 92: Canada Market Share, By Application, 2021

Figure 93: Brazil Market Value (US$ million) and Forecast, 2022 to 2032

Figure 94: Brazil Market Share, By Component, 2021

Figure 95: Brazil Market Share, By End-use, 2021

Figure 96: Brazil Market Share, By Application, 2021

Figure 97: Mexico Market Value (US$ million) and Forecast, 2022 to 2032

Figure 98: Mexico Market Share, By Component, 2021

Figure 99: Mexico Market Share, By End-use, 2021

Figure 100: Mexico Market Share, By Application, 2021

Figure 101: Germany Market Value (US$ million) and Forecast, 2022 to 2032

Figure 102: Germany Market Share, By Component, 2021

Figure 103: Germany Market Share, By End-use, 2021

Figure 104: Germany Market Share, By Application, 2021

Figure 105: United Kingdom Market Value (US$ million) and Forecast, 2022 to 2032

Figure 106: United Kingdom Market Share, By Component, 2021

Figure 107: United Kingdom Market Share, By End-use, 2021

Figure 108: United Kingdom Market Share, By Application, 2021

Figure 109: France Market Value (US$ million) and Forecast, 2022 to 2032

Figure 110: France Market Share, By Component, 2021

Figure 111: France Market Share, By End-use, 2021

Figure 112: France Market Share, By Application, 2021

Figure 113: Italy Market Value (US$ million) and Forecast, 2022 to 2032

Figure 114: Italy Market Share, By Component, 2021

Figure 115: Italy Market Share, By End-use, 2021

Figure 116: Italy Market Share, By Application, 2021

Figure 117: Netherlands Market Value (US$ million) and Forecast, 2022 to 2032

Figure 118: Netherlands Market Share, By Component, 2021

Figure 119: Netherlands Market Share, By End-use, 2021

Figure 120: Netherlands Market Share, By Application, 2021

Figure 121: Belgium Market Value (US$ million) and Forecast, 2022 to 2032

Figure 122: Belgium Market Share, By Component, 2021

Figure 123: Belgium Market Share, By End-use, 2021

Figure 124: Belgium Market Share, By Application, 2021

Figure 125: China Market Value (US$ million) and Forecast, 2022 to 2032

Figure 126: China Market Share, By Component, 2021

Figure 127: China Market Share, By End-use, 2021

Figure 128: China Market Share, By Application, 2021

Figure 129: Japan Market Value (US$ million) and Forecast, 2022 to 2032

Figure 130: Japan Market Share, By Component, 2021

Figure 131: Japan Market Share, By End-use, 2021

Figure 132: Japan Market Share, By Application, 2021

Figure 133: South Korea Market Value (US$ million) and Forecast, 2022 to 2032

Figure 134: South Korea Market Share, By Component, 2021

Figure 135: South Korea Market Share, By End-use, 2021

Figure 136: South Korea Market Share, By Application, 2021

Figure 137: Saudi Arabia Market Value (US$ million) and Forecast, 2022 to 2032

Figure 138: Saudi Arabia Market Share, By Component, 2021

Figure 139: Saudi Arabia Market Share, By End-use, 2021

Figure 140: Saudi Arabia Market Share, By Application, 2021

Figure 141: South Africa Market Value (US$ million) and Forecast, 2022 to 2032

Figure 142: South Africa Market Share, By Component, 2021

Figure 143: South Africa Market Share, By End-use, 2021

Figure 144: South Africa Market Share, By Application, 2021

Figure 145: Nigeria Market Value (US$ million) and Forecast, 2022 to 2032

Figure 146: Nigeria Market Share, By Component, 2021

Figure 147: Nigeria Market Share, By End-use, 2021

Figure 148: Nigeria Market Share, By Application, 2021